When SEB’s Co-Head of Retail Banking, Mika Burman Götz, visited Neola Medical’s headquarters in Lund, she was not only surrounded by innovation and cutting-edge research but also witnessed a vision for the future of modern healthcare—where technological advancements touch the very essence of human life.
“Neola Medical’s product truly goes straight to the heart, standing as a remarkable example of how research and technological innovation can genuinely become life-saving.”, says Mika Burman Götz, Co-Head of Retail Banking at SEB, as she reflects on the company’s mission to improve neonatal care worldwide.
From Niche Player to Major Bank Leadership
Mika Burman Götz, a key leader at SEB, brings a wealth of experience in digital transformation and business development. As Co-Head of SEB’s Swedish operations for private individuals and SMEs, she leads a team of over 2,300 employees who manage both digital and in-person customer service and sales.
Her journey into banking was anything but conventional. With a strong passion for financial markets and human behavior, Mika Burman Götz’s early career was marked by initiatives to promote financial literacy, empowering individuals to make informed investment decisions. After leading Unga Aktiesparare and Nordnet, she realized that to create broad, industry-wide change, she needed the scale and influence of a larger institution—prompting her move to SEB.
The Transformative Power of Technology
At SEB, Mika Burman Götz has spearheaded the bank’s digital transformation, focusing on leveraging cutting-edge technologies to improve customer experiences. This focus aligns with key global trends in transparency, enhanced service delivery, and sustainability. For Mika Burman Götz, digital and technological advancements aren’t just about efficiency—they are essential tools for driving positive societal change.
Similarly, the MedTech industry is harnessing the transformative power of technology to revolutionize healthcare by seamlessly integrating advanced systems into medical practice. Neola Medical is proud to be at the forefront of a new era in this field, by developing Neola®, a medical device specifically designed to meet the unmet clinical needs in neonatal care.
Having key leaders from a major financial institution like SEB visit us highlights the increasing recognition of the critical role MedTech plays in shaping the future of healthcare technology. It was a valuable opportunity to showcase how our continuous lung monitoring device, Neola®, has the potential to not only save lives and enhance patient outcomes but also improve neonatal care globally.
– CEO Hanna Sjöström at Neola Medical
When Technology and Compassion Intersect
Neola Medical deeply values Mika Burman Götz’s commitment to innovation and her acknowledgment of the company’s mission: transforming neonatal care by providing healthcare professionals with the tools they need to make life-saving decisions.
The highlight of her visit, accompanied by SEB colleagues from the office in Lund, was the presentation of Neola®. The demonstration sparked significant interest amongst SEB’s leadership, as they were captivated by Neola®’s ability to address key healthcare challenges and its poteintial to be a pivotal player in the future of healthcare innovation.
I am truly pleased to have had the opportunity to visit Neola Medical’s headquarters and gain a deeper understanding of their operations. Neola Medical’s product truly goes straight to the heart, standing as a remarkable example of how research and technological innovation can genuinely become life-saving. I am excited to follow their progress and future developments with great interest.
– Mika Burman Götz, Co-Head of Retail Banking at SEB
Leveraging Innovation to Drive Positive Change
The visit by SEB’s leaders to Neola Medical’s headquarters reflects a growing interest in supporting emerging technologies that align with a broader vision for sustainable and impactful growth. As the healthcare landscape continues to evolve, potential collaborations like these could have the ability to accelerate advancements that will redefine healthcare for the world’s most vulnerable patients.